The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

Rezultaty

Website with name, logo, project description, and partner information available, plus posting of recent advances and upcoming events online.

Clinical case reports from all affiliated centers treating Long-COVID patients

Provide clinical evidence and specification of patient cohort disease criteria.

Publikacje

International Journal of Molecular Sciences

Autorzy: Arora et al.
Opublikowane w: International Journal of Molecular Sciences, 2023, ISSN 1422-0067
Wydawca: Basel MDPI Center 2000-
DOI: 10.3390/ijms232214057

From rare disorders of immunity to common determinants of infection: Following the mechanistic thread

Autorzy: Casanova & Abel
Opublikowane w: Cell, 2022, ISSN 1097-4172
Wydawca: Cell
DOI: 10.1016/j.cell.2022.07.004

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

Autorzy: Zhang et al.
Opublikowane w: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Wydawca: Rockefeller University Press
DOI: 10.1084/jem.20220131

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage

Autorzy: Arora et al.
Opublikowane w: The Lancet Infectious Diseases, 2023, ISSN 1474-4457
Wydawca: The Lancet
DOI: 10.1016/S1473-3099(22)00831-3

Human inherited complete STAT2 deficiency underlies inflammatory viral diseases

Autorzy: Bucciol et al.
Opublikowane w: Journal of Clinical Investigation, 2023, ISSN 1558-8238
Wydawca: American Society for Clinical Investigation
DOI: 10.1172/JCI168321

Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75

Autorzy: Arora et al.
Opublikowane w: The Lancet Infectious Diseases, 2022, ISSN 1474-4457
Wydawca: The Lancet
DOI: 10.1016/S1473-3099(22)00591-6

Pharmaceuticals

Autorzy: Centofanti et al.
Opublikowane w: Pharmaceuticals (Basel), 2024, ISSN 1424-8247
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ph16020240

Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

Autorzy: Lee et al.
Opublikowane w: Science, 2022, ISSN 1095-9203
Wydawca: Science
DOI: 10.1126/science.abo3627

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Autorzy: Zhang et al.
Opublikowane w: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Wydawca: Rockefeller University Press
DOI: 10.1084/jem.20220514

Pathogens

Autorzy: Skouboe et al.
Opublikowane w: Pathogens, 2022, ISSN 2076-0817
Wydawca: Basel MDPI AG 2012-
DOI: 10.3390/pathogens12020310

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

Autorzy: Budhadev et al.
Opublikowane w: JACS Au, 2023, ISSN 2691-3704
Wydawca: Washington, DC American Chemical Society [2021]-
DOI: 10.1021/jacsau.3c00163

Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity

Autorzy: Tangye et al.
Opublikowane w: Journal of Allergy and Clinical Immunology, 2022, ISSN 2772-8293
Wydawca: New York Elsevier, Inc.
DOI: 10.1016/j.jaci.2022.11.010

Nature Communications

Autorzy: Hoffmann et al.
Opublikowane w: Nature Communications, 2023, ISSN 2041-1723
Wydawca: Nature Publishing Group
DOI: 10.1038/s41467-023-39147-4

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs

Autorzy: von Gunten et al.
Opublikowane w: Frontiers in Immunology, 2023, ISSN 2832-4404
Wydawca: Lausanne Frontiers Media S.A. 2010-
DOI: 10.48350/181810

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies

Autorzy: Arora et al.
Opublikowane w: The Lancet Infectious Diseases, 2022, ISSN 1474-4457
Wydawca: The Lancet
DOI: 10.1016/S1473-3099(22)00733-2

The genetic and evolutionary determinants of COVID-19 susceptibility

Autorzy: Kerner et al.
Opublikowane w: European Journal of Human Genetics, 2022, ISSN 1476-5438
Wydawca: Nature
DOI: 10.1038/s41431-022-01141-7

COVID-19: S-Peptide RBD 484–508 Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients

Autorzy: Murdocca et al.
Opublikowane w: Viruses, 2023, ISSN 1999-4915
Wydawca: Basel MDPI 2009-
DOI: 10.3390/v15071417

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

Autorzy: Mathian et al.
Opublikowane w: Annals of the Rheumatic Diseases, 2022, ISSN 1468-2060
Wydawca: BMJ Group on behalf of the European League Against Rheumatism
DOI: 10.1136/ard-2022-222549

Viruses

Autorzy: Campos-Gonzalez et al.
Opublikowane w: Viruses, 2024, ISSN 1999-4915
Wydawca: Basel MDPI 2009-
DOI: 10.3390/v15030789

Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3

Autorzy: Zhang et al.
Opublikowane w: The Lancet Infectious Diseases, 2023, ISSN 1474-4457
Wydawca: Elsevier
DOI: 10.1016/S1473-3099(23)00547-9

Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

Autorzy: Bucciol et al.
Opublikowane w: Journal of Allergy and Clinical Immunology, 2023, ISSN 2772-8293
Wydawca: New York Elsevier, Inc.
DOI: 10.1016/j.jaci.2023.02.003

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

Autorzy: Sokal et al.
Opublikowane w: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Wydawca: Rockefeller University Press
DOI: 10.1084/jem.20220258

Rezultaty

Publikacje

Udostępnij tę stronę

Pobierz